Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors

NCT04592354 is registered in ClinicalTrials.gov with Terra Biological LLC as lead sponsor.

NCT NCT04592354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04592354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors
Lead sponsor
Terra Biological LLC
Phase
Not applicable
Overall status
Unknown status
Start date
October 15, 2020
Completion date
June 15, 2021
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment of fatigue after resolution of covid-19 infection